The U.S. Food and Drug Administration (FDA) said on Feb. 25 that although there are currently no reported drug shortages due to the coronavirus outbreak, it anticipates the medical supply chain will likely be affected.
Stephen Hahn, commissioner of the FDA, told reporters Tuesday the agency has been proactively reaching out to hundreds of medical product manufacturers to gauge potential disruptions to critical medical products in the United States, and none have yet reported anticipated shortages.
